Abstracts tagged "Ehlers-Danlos"

Abstract Number: 0254 • ACR Convergence 2023
Microvascular and Cutaneous Assessment in Adult Patients with Hypermobile Ehlers-Danlos Syndrome
Alberto Sulli¹, Francesca Lalli², Elvis Hysa², Andrea Cere¹, Alessandro Pinelli², Silvia Sammorì¹, Emanuele Gotelli¹, Carmen Pizzorni¹, Marco Castori³, Fransiska Malfait⁴, Vanessa Smith⁵ and Maurizio Cutolo⁶, ¹Laboratory of Experimental Rheumatology and Academic Division of Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital, Genoa, Italy, ²Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genova, Italy, ³Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy, ⁴Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium, ⁵Ghent University Hospital, Gent, Belgium, ⁶Laboratory of Experimental Rheumatology, Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic, Genova, Italy
Background/Purpose: Hypermobile Ehlers-Danlos syndrome (hEDS) is a hereditary connective tissue disease characterized by joint hypermobility, chronic musculoskeletal pain, and systemic manifestations, primarily caused by defects…
Abstract Number: 1838 • ACR Convergence 2023
The Burden of Dysautonomia in Patients Suffering from Pathologies Associated with Generalized Joint Hypermobility
Alizée Perrein¹, Fabien Pontille¹, Paul Decker², david Attali³, Thomas Moulinet⁴ and Roland Jaussaud⁵, ¹Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre-les-Nancy, France, ²Nancy hospital, France, Nancy, France, ³Université Paris Cité, Laboratoire Psychopathologie et Processus de Santé, Boulogne-Billancourt, France, ⁴Department of Internal Medicine, Centre hospitalier universitaire de Nancy, Nancy, France, ⁵Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre Les Nancy, France
Background/Purpose: Hypermobility spectrum disorders (HSD) and hypermobile Ehlers Danlos syndrome (hEDS) are among the conditions associated with generalized joint hypermobility (GJH). Alongside myofascial and skeletal…
Abstract Number: 0194 • ACR Convergence 2022
A Survey of Patients with Ehlers Danlos Syndrome and Their Interest in Multidisciplinary Care
Jordan Jones¹, William Black², Wendy Cogan³ and Elisabeth Callen⁴, ¹Children's Mercy Kansas City, Kansas City, MO, ²University of Kansas School of Medicine, Kansas City, KS, ³EDSKC Collaboration Inc., Kansas City, MO, ⁴American Academy of Family Physicians, Leawood, KS
Background/Purpose: Ehlers-Danlos Syndrome (EDS) represents a family of heritable connective tissue disorders with overlapping phenotypic features, frequently including joint hypermobility, tissue fragility, and skin hyperextensibility,…
Abstract Number: 0548 • ACR Convergence 2022
Postural Orthostatic Tachycardia Syndrome, Small Fiber Neuropathy, and Systemic Inflammation: Are They Related?
Elizabeth Bettini, Carolyn Ramwell, Sangeeta Sule and Jeffery Moak, Children's National Hospital, Washington, DC
Background/Purpose: Postural Orthostatic Tachycardia Syndrome (POTS) is a dysautonomia associated with chronic autonomic and neuropathic symptoms, including pain in multiple body regions, paresthesia, fatigue, brain…
Abstract Number: 1215 • ACR Convergence 2022
Identifying a Pain Signature in Classical Ehlers-Danlos Syndrome: Preliminary Results from Questionnaires and Experimental Pain Testing
Marlies Colman, Inge De Wandele, Lies Rombaut, Delfien Syx, Fransiska Malfait and Jessica Van Oosterwijck, Ghent University, Ghent, Belgium
Background/Purpose: Chronic pain is one of the most common complaints of individuals with Ehlers-Danlos syndrome (EDS) and the effects of the existing therapeutical modalities are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].